Patent · US Active

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

US12295926B1 · kind B1 · utility

0Cited by

266References

7Claims

0Family size

Assignee

Flamel Ireland Limited · IE

Inventors

Julien Grassot · L'Essart Mador, FR
David Monteith · L'Essart Mador, FR
Hervé Guillard · Villeurbanne, FR
Claire Mégret · L'Essart Mador, FR
Jean-François Dubuisson · L'Essart Mador, FR

Key dates

Filing date	Apr 28, 2022
Grant date	May 13, 2025
Priority date	—
Expiry date	Apr 28, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.